Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -112,477 | -83,496 | -51,464 | -24,528 | -98,036 |
| Depreciation Amortization | 8,030 | 6,112 | 4,153 | 1,987 | 7,678 |
| Accounts receivable | 606 | 581 | 372 | -38 | -589 |
| Accounts payable and accrued liabilities | -1,131 | -2,474 | -1,735 | -1,752 | 460 |
| Other Working Capital | -6,904 | -2,700 | -3,859 | -4,596 | 2,018 |
| Other Operating Activity | 34,307 | 17,142 | 6,486 | 4,371 | 13,687 |
| Operating Cash Flow | $-77,569 | $-64,835 | $-46,047 | $-24,556 | $-74,782 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -522 | -554 | -551 | -131 | -1,617 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -59,335 |
| Sale Of Investment | 49,379 | 45,229 | 35,679 | 18,163 | 71,362 |
| Investing Cash Flow | $48,857 | $44,675 | $35,128 | $18,032 | $10,410 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -47 | -30 | -14 | -8 | -31 |
| Common Stock Issued | 40,039 | 40,119 | 9,124 | 4,695 | 68,335 |
| Other Financing Activity | 34,096 | 34,198 | 0 | 0 | -195 |
| Financing Cash Flow | $74,088 | $74,287 | $9,110 | $4,687 | $68,109 |
| Exchange Rate Effect | -228 | -41 | -18 | 28 | -98 |
| Beginning Cash Position | 48,668 | 48,668 | 48,668 | 48,668 | 45,029 |
| End Cash Position | 93,816 | 102,754 | 46,841 | 46,859 | 48,668 |
| Net Cash Flow | $45,148 | $54,086 | $-1,827 | $-1,809 | $3,639 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,569 | -64,835 | -46,047 | -24,556 | -74,782 |
| Capital Expenditure | -522 | -554 | -551 | -131 | -1,617 |
| Free Cash Flow | -78,091 | -65,389 | -46,598 | -24,687 | -76,399 |